Dag-uman, Chrisnalyn .

HRN: 17-56-57  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/05/2025
AMPICILLIN 1GM (VIAL)
06/05/2025
06/11/2025
IV
2g
Q6
G2P1(1001) PU 39 6/7 Weeks AOG BY LMP; CIL; PROM X 10 Hrs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: